These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29531548)

  • 21. Bcl-6 protein expression by follicle center lymphomas. A marker for differentiating follicle center lymphomas from other low-grade lymphoproliferative disorders.
    Raible MD; Hsi ED; Alkan S
    Am J Clin Pathol; 1999 Jul; 112(1):101-7. PubMed ID: 10396291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemistry with apoptotic-antiapoptotic proteins (p53, p21, bax, bcl-2), c-kit, telomerase, and metallothionein as a diagnostic aid in benign, borderline, and malignant serous and mucinous ovarian tumors.
    Ozer H; Yenicesu G; Arici S; Cetin M; Tuncer E; Cetin A
    Diagn Pathol; 2012 Sep; 7():124. PubMed ID: 22995373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential expression of cell survival and cell cycle regulatory proteins in cutaneous squamoproliferative lesions.
    Wrone-Smith T; Bergstrom J; Quevedo ME; Reddy V; Gutierrez-Steil C; Nickoloff BJ
    J Dermatol Sci; 1999 Jan; 19(1):53-67. PubMed ID: 9890376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of the Bcl-2 and p53 protein expression in the lymphoproliferative lesions in the upper Egypt.
    Hussein MR; Al-Sabae TM; Georgis MN
    Cancer Biol Ther; 2005 Mar; 4(3):324-8. PubMed ID: 15846077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical analysis of Bcl-2, Bcl-X, Mcl-1, and Bax in tumors of central and peripheral nervous system origin.
    Krajewski S; Krajewska M; Ehrmann J; Sikorska M; Lach B; Chatten J; Reed JC
    Am J Pathol; 1997 Mar; 150(3):805-14. PubMed ID: 9060818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of p53 protein and the apoptotic regulatory molecules Bcl-2, Bcl-XL, and Bax in locally advanced squamous cell carcinoma of the lung.
    Shabnam MS; Srinivasan R; Wali A; Majumdar S; Joshi K; Behera D
    Lung Cancer; 2004 Aug; 45(2):181-8. PubMed ID: 15246189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significance of apoptosis related proteins on malignant transformation of ovarian tumors: A comparison between Bcl-2/Bax ratio and p53 immunoreactivity.
    Zeren T; Inan S; Vatansever HS; Sayhan S
    Acta Histochem; 2014 Oct; 116(8):1251-8. PubMed ID: 25108507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of Bcl-2, but not Bax, correlates with estrogen receptor status and tumor proliferation in invasive breast carcinoma.
    Yang Q; Sakurai T; Jing X; Utsunomiya H; Shan L; Nakamura Y; Nakamura M; Oura S; Suzuma T; Yoshimura G; Umemura T; Kokawa Y; Kakudo K
    Pathol Int; 1999 Sep; 49(9):775-80. PubMed ID: 10504548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of p53, p21/waf1, bcl-2, bax, Rb and Ki67 proteins in Hodgkin's lymphomas.
    Kanavaros P; Stefanaki K; Vlachonikolis J; Eliopoulos G; Kakolyris S; Rontogianni D; Gorgoulis V; Georgoulias V
    Histol Histopathol; 2000 Apr; 15(2):445-53. PubMed ID: 10809363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histopathologic features and expression of Bcl-2 and p53 proteins in primary gastric lymphomas.
    Dogusoy G; Karayel FA; Göcener S; Göksel S
    Pathol Oncol Res; 1999; 5(1):36-40. PubMed ID: 10079376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of Bcl-xL, Bax, and p53 in primary tumors and lymph node metastases in oral squamous cell carcinoma.
    Baltaziak M; Duraj E; Koda M; Wincewicz A; Musiatowicz M; Kanczuga-Koda L; Szymanska M; Lesniewicz T; Musiatowicz B
    Ann N Y Acad Sci; 2006 Dec; 1090():18-25. PubMed ID: 17384243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers.
    Krajewska M; Krajewski S; Epstein JI; Shabaik A; Sauvageot J; Song K; Kitada S; Reed JC
    Am J Pathol; 1996 May; 148(5):1567-76. PubMed ID: 8623925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of bax, bcl-2, and p53 staining in primary osteosarcoma.
    Kaseta MK; Khaldi L; Gomatos IP; Tzagarakis GP; Alevizos L; Leandros E; Papagelopoulos PJ; Soucacos PN
    J Surg Oncol; 2008 Mar; 97(3):259-66. PubMed ID: 18161867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cluster analysis of apoptosis-associated bcl2 family proteins in diffuse large B-cell lymphomas. Relations with the apoptotic index, the proliferation profile and the B-cell differentiation immunophenotypes.
    Bai M; Skyrlas A; Agnantis NJ; Kamina S; Kitsoulis P; Kanavaros P
    Anticancer Res; 2004; 24(5A):3081-8. PubMed ID: 15517919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bcl-2, Bcl-X, Bax, and Bak expression in short- and long-lived patients with diffuse large B-cell lymphomas.
    Bairey O; Zimra Y; Shaklai M; Okon E; Rabizadeh E
    Clin Cancer Res; 1999 Oct; 5(10):2860-6. PubMed ID: 10537354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BCL-2 expression correlates with lower proliferative activity in the intermediate- and high-grade non-Hodgkin's lymphomas: an Eastern Cooperative Oncology Group and Southwest Oncology Group cooperative laboratory study.
    Winter JN; Andersen J; Reed JC; Krajewski S; Variakojis D; Bauer KD; Fisher RI; Gordon LI; Oken MM; Jiang S; Jeffries D; Domer P
    Blood; 1998 Feb; 91(4):1391-8. PubMed ID: 9454770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
    Plosker GL; Figgitt DP
    Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular control of the cell cycle in cancer: biological and clinical aspects.
    Møller MB
    Dan Med Bull; 2003 May; 50(2):118-38. PubMed ID: 12812137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bax immunohistochemical expression in breast carcinoma: a study with long term follow-up.
    Veronese S; Mauri FA; Caffo O; Scaioli M; Aldovini D; Perrone G; Galligioni E; Doglioni C; Dalla Palma P; Barbareschi M
    Int J Cancer; 1998 Feb; 79(1):13-8. PubMed ID: 9495351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical expression of PCNA, p53, bax and bcl-2 in oral lichen planus and epithelial dysplasia.
    Sousa FA; Paradella TC; Carvalho YR; Rosa LE
    J Oral Sci; 2009 Mar; 51(1):117-21. PubMed ID: 19325208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.